| Completed | Condition of Submental Fullness and Treatment Outcomes Registry Submental Fullness | — | 2015-05-11 |
| Completed | Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subj Moderate to Severe Convexity of Submental Fat, Safety, Efficacy | Phase 3 | 2014-04-01 |
| Completed | Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat Moderate to Severe Convexity of Submental Fat, Safety, Efficacy | Phase 3 | 2014-01-01 |
| Completed | Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Submental Fat, Healthy | Phase 3 | 2013-12-01 |
| Completed | Patient Experience Study of Deoxycholic Acid Injection Moderate or Severe Submental Fullness | Phase 3 | 2013-12-01 |
| Completed | Evaluation of the Effect of ATX-101 on QT/QTc Intervals Healthy | Phase 1 | 2012-10-01 |
| Completed | Open-Label Pharmacokinetic Study of Final Formulations of ATX-101 Healthy | Phase 1 | 2012-06-01 |
| Completed | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneo Moderate or Severe Submental Fullness | Phase 3 | 2012-03-01 |
| Completed | Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneo Moderate or Severe Submental Fullness | Phase 3 | 2012-02-01 |
| Completed | To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101 Healthy | Phase 1 | 2011-10-01 |
| Completed | Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area Moderate or Severe Submental Fullness | Phase 3 | 2011-08-01 |
| Completed | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Moderate or Severe Submental Fullness | Phase 3 | 2011-01-01 |
| Completed | Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Moderate or Severe Submental Fullness | Phase 3 | 2010-12-01 |
| Completed | Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue Healthy | Phase 1 | 2010-12-01 |
| Completed | Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome M Moderate or Severe Submental Fullness | Phase 2 | 2009-12-01 |
| Completed | Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Submental Fat, Healthy | Phase 2 | 2009-02-01 |
| Completed | ATX-101 Abdominoplasty Characteristics of Subcutaneous Fat | Phase 1 | 2008-11-01 |
| Completed | Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Moderate or Severe Submental Fullness | Phase 2 | 2008-04-01 |
| Completed | Dose-Escalation Safety and Pharmacokinetic Study of ATX-101 Healthy | Phase 1 | 2008-01-01 |
| Completed | Phase 2 Study for the Treatment of Superficial Lipomas Lipoma | Phase 2 | 2007-11-01 |
| Completed | Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Moderate or Severe Submental Fullness | Phase 1 / Phase 2 | 2007-08-01 |
| Completed | Deoxycholic Acid Injection for the Treatment of Superficial Lipomas Lipoma | Phase 1 | 2007-01-01 |
| Completed | A Study to Assess Injection Comfort of Two Formulations of ATX-101 Healthy | Phase 1 | — |